Invention Grant
- Patent Title: Method for treating active bleeding by sequentially applying a biocompatible hemostatic composition and a sealant composition
-
Application No.: US16959994Application Date: 2019-01-10
-
Publication No.: US11998653B2Publication Date: 2024-06-04
- Inventor: Xin Ji , Xueshen Shi , Xiaoguang Zhang
- Applicant: Beijing Universal Likang Technology Co., LTD.
- Applicant Address: CN Beijing
- Assignee: Beijing Universal Likang Technology Co., LTD.
- Current Assignee: Beijing Universal Likang Technology Co., LTD.
- Current Assignee Address: CN Beijing
- Agency: Novel IP
- Priority: CN 1810031082.4 2018.01.12
- International Application: PCT/CN2019/071108 2019.01.10
- International Announcement: WO2019/137414A 2019.07.18
- Date entered country: 2020-07-02
- Main IPC: A61L24/00
- IPC: A61L24/00 ; A61L24/04 ; A61L24/08 ; A61L24/10 ; C08L3/02 ; C08L5/08 ; C08L71/02

Abstract:
The present specification describes a biocompatible hemostatic composition and a biocompatible tissue sealant, which when used in combination provides a safe and effective method of achieving hemostasis. The biocompatible composition and sealant may be applied either on a surface of the patient's body, or inside the body cavity. The combination may be used to control bleeding from external wounds and internal injuries, as well as to minimize bleeding during surgical procedures.
Public/Granted literature
- US20210060204A1 METHOD FOR TREATING ACTIVE BLEEDING USING BIOCOMPATIBLE HEMOSTATIC AND SEALANT COMPOSITIONS Public/Granted day:2021-03-04
Information query